Shattuck Labs Inc
NASDAQ:STTK 3:59:59 PM EDT
| Market Cap (Intraday) | 1.25B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $30.13 |
| 50-Day MA | $35.41 |
| 200-Day MA | N/A |
Shattuck Labs Inc Stock, NASDAQ:STTK
1018 West 11th Street, Suite 100, Austin, Texas 78703
United States of America
Phone: +1.919.864.2700
Number of Employees: 59
Description
Shattuck Labs, Inc. engages in the research and development of Agonist Redirected Checkpoint (ARC) platform. It develops a novel class of biologic medicines, capable of multifunctional activity, with potential applications in oncology and autoimmune diseases. The company was founded by Josiah C. Hornblower and Taylor Schreiber in 2016 and is headquartered in Austin, TX.